Clinical Trial

Noninvasive Artificial Venous Stasis for Reperfusion in STEMI

Study acronym: RE-START
Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, randomized study was designed to evaluate whether the noninvasive artificial venous stasis / RE-START procedure, administered prior to primary percutaneous coronary intervention, increases the frequency of spontaneous coronary reperfusion in the infarct-related artery.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-11
Trial Details
NCT Number NCT07689591
Lead Sponsor Firat University
Conditions STEMI - ST Elevation Myocardial Infarction
Enrollment 500 participants
Start Date 2026-07-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-10